How have PKTX shares performed in 2024?

ProtoKinetix's stock was trading at $0.0190 at the beginning of the year. Since then, PKTX stock has decreased by 12.6% and is now trading at $0.0166. View the best growth stocks for 2024 here .

Are investors shorting ProtoKinetix?

ProtoKinetix saw a decrease in short interest in April. As of April 15th, there was short interest totaling 1,600 shares, a decrease of 54.3% from the March 31st total of 3,500 shares. Based on an average daily volume of 130,400 shares, the days-to-cover ratio is currently 0.0 days. View ProtoKinetix's Short Interest .

What other stocks do shareholders of ProtoKinetix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProtoKinetix investors own include Fulcrum Therapeutics (FULC) , Rockwell Medical (RMTI) , Provention Bio (PRVB) , VIVUS (VVUS) , Actinium Pharmaceuticals (ATNM) , Chimerix (CMRX) , Rexahn Pharmaceuticals (REXN) , SCYNEXIS (SCYX) and VBI Vaccines (VBIV) .

How do I buy shares of ProtoKinetix?

Shares of PKTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:PKTX

ProtoKinetix (PKTX) Stock Price, News & Analysis

→ Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad)

Free PKTX Stock Alerts

$0.02

0.00 (0.00%)

(As of 05/16/2024 ET)

Compare

Today's Range: $0.0166
▼
$0.0166
50-Day Range: $0.0142
▼
$0.0199
52-Week Range: $0.01
▼
$0.03

Volume: 10,000 shs
Average Volume: 137,860 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Financials SEC Filings Short Interest

Get ProtoKinetix alerts:

Ad True Market Insiders

The 1,000X Crypto Playbook

Chris Rowe has created a “Crypto Playbook” that anyone can follow… potentially turning small investments into pers

#1 Crypto for 2024, completely FREE.

About ProtoKinetix Stock (OTCMKTS:PKTX)

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.

PKTX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PKTX Stock News Headlines

April 16, 2024 | markets.businessinsider.com

Nauticus Robotics And 2 Other Stocks Under $3 Insiders Are Buying

November 18, 2023 | finance.yahoo.com

ProtoKinetix, Incorporated (PKTX)

November 12, 2023 | morningstar.com

ProtoKinetix Inc PKTX

October 30, 2023 | benzinga.com

Insiders Buying ProtoKinetix And 2 Other Stocks Under $2

June 6, 2023 | finance.yahoo.com

Research Paper Incorporating ProtoKinetix AAGP® Submitted to Scientific Journal for Publication

October 10, 2022 | reuters.com

PKTX.PK - ProtoKinetix, Inc. | Stock Price & Latest News | Reuters

October 6, 2022 | benzinga.com

ProtoKinetix Stock (OTC:PKTX), Dividends

July 20, 2022 | tmcnet.com

ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants

July 17, 2022 | uk.investing.com

Around $12 Million Bet On Sonim Technologies? 4 Penny Stocks Insiders Are Buying

July 15, 2022 | insidermonkey.com

Hedge Fund and Insider Trading News: Alan Howard, Cathie Wood, Elliott Management, Bridgewater Associates, Sonim Technologies Inc (SONM), ProtoKinetix, Incorporated (PKTX), and More

January 14, 2022 | finance.yahoo.com

ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only

November 23, 2021 | finance.yahoo.com

ProtoKinetix Announces Selection of AAGP® Candidate Formulations for Treatment of Dry Eye Disease

August 9, 2021 | benzinga.com

4 Penny Stocks Insiders Are Buying

See More Headlines

Receive PKTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProtoKinetix and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:PKTX
Previous Symbol: NASDAQ:PKTX
CUSIP: N/A
CIK: 1128189
Web: www.protokinetix.com
Phone: (330) 445-4971
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. Clarence Edward Smith (Age 60)
Chairman, President & CEO
Mr. Michael Richard Guzzetta CPA (Age 66)
Chief Financial Officer
Comp: $60k

Key Competitors

View All Competitors

PKTX Stock Analysis - Frequently Asked Questions

How have PKTX shares performed in 2024?: ProtoKinetix's stock was trading at $0.0190 at the beginning of the year. Since then, PKTX stock has decreased by 12.6% and is now trading at $0.0166.
View the best growth stocks for 2024 here.
Are investors shorting ProtoKinetix?: ProtoKinetix saw a decrease in short interest in April. As of April 15th, there was short interest totaling 1,600 shares, a decrease of 54.3% from the March 31st total of 3,500 shares. Based on an average daily volume of 130,400 shares, the days-to-cover ratio is currently 0.0 days.
View ProtoKinetix's Short Interest.
What other stocks do shareholders of ProtoKinetix own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ProtoKinetix investors own include Fulcrum Therapeutics (FULC), Rockwell Medical (RMTI), Provention Bio (PRVB), VIVUS (VVUS), Actinium Pharmaceuticals (ATNM), Chimerix (CMRX), Rexahn Pharmaceuticals (REXN), SCYNEXIS (SCYX) and VBI Vaccines (VBIV).
How do I buy shares of ProtoKinetix?: Shares of PKTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PKTX) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial